| RS1188686549 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1188692048 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1188694060 |
PDX1
|
Health Risk |
Uncertain risk allele |
Pancreatic hypoplasia, Pancreatic hypoplasia |
| RS1188709614 |
BRDT
|
Health Risk |
Pathogenic |
Premature ovarian failure, Premature ovarian failure |
| RS11887534 |
ABCG5;ABCG8
|
Health Risk |
Benign/Likely benign; association |
Gallbladder disease 4, Sitosterolemia |
| RS1188753950 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1188755325 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1188757026 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS1188760861 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS11887722 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1188774860 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1188776082 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1188804374 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS1188811827 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1188823834 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1188823925 |
COL4A1
|
Health Risk |
Pathogenic |
— |
| RS1188834464 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1188835973 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1188844823 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1188846190 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS11888704 |
HPCAL1
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS1188885214 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1188895680 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1188916145 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1188933026 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1188943579 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
LZTR1-related disorder, LZTR1-related disorder |
| RS1188949540 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1188975716 |
ADAM9
|
Health Risk |
Pathogenic |
— |
| RS11889925 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Alstrom syndrome |
| RS1189004291 |
GRM6
|
Health Risk |
Pathogenic |
— |
| RS1189009603 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1189015572 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 10, LZTR1-related schwannomatosis |
| RS1189024951 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1189025914 |
HAMP
|
Health Risk |
Pathogenic |
Hemochromatosis type 2B, Hemochromatosis type 2B |
| RS1189027155 |
AP5Z1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS1189039397 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1189054127 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1189071165 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1189095338 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS1189098622 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1189106357 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1189108407 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1189111600 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
MED12-related disorder, FG syndrome |
| RS1189127007 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1189134560 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS1189153218 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1189155420 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1189167614 |
STRC
|
Health Risk |
Pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS11891778 |
ABCA12
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4A |
| RS1189201208 |
COQ9
|
Health Risk |
Conflicting classifications of pathogenicity |
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome, Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome |
| RS1189203530 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1189206125 |
GRM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1189219556 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS1189239082 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1189241211 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS1189248208 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS1189252877 |
ALG13
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 36 |
| RS1189289587 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1189294231 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1189298981 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS1189313564 |
FKRP
|
Health Risk |
Pathogenic |
— |
| RS11893228 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS1189324317 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS1189348665 |
F8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1189355322 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1189364625 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS1189366704 |
YY1
|
Health Risk |
Pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS1189374970 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1189377616 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS1189377845 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1189379541 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-Winter syndrome 1, Inborn genetic diseases |
| RS1189381456 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1189382722 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1189399471 |
ASPM
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1189432427 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS1189450557 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1189454389 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS1189469219 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1189478751 |
C2CD3
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1189479619 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1189502123 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS1189512943 |
WFS1
|
Health Risk |
Pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1189520104 |
TCIRG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1189529370 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1189538200 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS1189539018 |
PIKFYVE
|
Health Risk |
Likely pathogenic |
— |
| RS1189543766 |
LRIG2
|
Health Risk |
Pathogenic |
— |
| RS1189551206 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS1189557869 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1189568492 |
CTSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS1189607438 |
COL4A3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Alport syndrome |
| RS1189622818 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1189623251 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1189625999 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome, Gordon syndrome |
| RS1189630738 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1189644919 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1189650128 |
FOXRED1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1189678912 |
CEP104
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS1189683846 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1189685462 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |